Submit a Release
Home
All
ESG
Health
Technology
Finance
Contributors
Sub Menu
Submit a Release
main-search-pop
Main menu
Camurus announces expansion of Lilly collaboration
Contributed by:
PR Newswire
Tags
Camurus-Lily
More Like This
Camurus and Lilly enter collaboration and license agreement for long-acting FluidCrystal® incretins
Camurus announces FDA acceptance of NDA resubmission for Oclaiz™ for the treatment of acromegaly
Cambrex Announces Strategic Agreement with Lilly to Support Biotech Collaborator Manufacturing
Camurus announces approval of Oczyesa® for the treatment of acromegaly in the UK
Camurus reports positive topline results for CAM2056, semaglutide monthly depot
Camurus announces positive Phase 3 results from the ACROINNOVA 2 study of octreotide SC depot (CAM2029) in acromegaly patients
Camurus' Oczyesa® receives marketing authorization for treatment of acromegaly in the EU
Amacathera Collaborates With Leading Global Pharmaceutical Company To Develop Single-Injection, Long-Acting Biologic Using Its Advanced Hydrogel Delivery Platform, Amacagel™
